MIR1302-11: A Drug Target / Disease Biomarker (G100422919)
MIR1302-11: A Drug Target / Disease Biomarker
MIR1302-11 is a protein that is expressed in various tissues of the body, including the brain, lungs, heart, and kidneys. It is a member of the Mir1 family of transmembrane proteins, which are known for their role in cell signaling and inflammation.
One of the main functions of MIR1302-11 is to regulate the production of pro-inflammatory cytokines, which are important mediators of inflammation and infection. Specifically, MIR1302-11 has been shown to inhibit the production of these cytokines by suppressing the activation and function of certain immune cells, such as T cells and macrophages.
This protein has also been shown to play a role in the regulation of cellular signaling pathways that are involved in inflammation, including the production of pro-inflammatory cytokines. For example, MIR1302-11 has been shown to inhibit the activation and function of several different signaling pathways, including the TGF-β pathway and the NF-kappa-B pathway.
MIR1302-11 has also been shown to have several potential drug-like properties, including its ability to inhibit the production of pro-inflammatory cytokines and its ability to interact with certain signaling pathways. This suggests that MIR1302-11 may be a useful drug target or biomarker for the development of new treatments for a variety of inflammatory diseases.
In conclusion, MIR1302-11 is a protein that has been shown to play a critical role in the regulation of pro-inflammatory cytokines and cellular signaling pathways. Its potential drug-like properties make it a promising target for the development of new treatments for inflammatory diseases. Further research is needed to fully understand the role of MIR1302-11 in these processes and to develop new treatments based on this protein.
Protein Name: MicroRNA 1302-11
The "MIR1302-11 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR1302-11 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR1302-2 | MIR1302-3 | MIR1302-4 | MIR1302-5 | MIR1302-6 | MIR1302-7 | MIR1302-8 | MIR1302-9 | MIR1303 | MIR1304 | MIR1305 | MIR1306 | MIR1307 | MIR130A | MIR130B | MIR132 | MIR1321 | MIR1322 | MIR1323 | MIR1324 | MIR133A1 | MIR133A1HG | MIR133A2 | MIR133B | MIR134 | MIR1343 | MIR135A1 | MIR135A2 | MIR135B | MIR136 | MIR137 | MIR137HG | MIR138-1 | MIR138-2 | MIR139 | MIR140 | MIR141 | MIR142 | MIR143 | MIR144 | MIR145 | MIR1468 | MIR1469 | MIR146A | MIR146B | MIR1470 | MIR1471 | MIR147A | MIR147B | MIR148A | MIR148B | MIR149 | MIR150 | MIR151A | MIR151B | MIR152 | MIR153-1 | MIR153-2 | MIR1537 | MIR1538 | MIR1539 | MIR154 | MIR155 | MIR155HG | MIR1587 | MIR15A | MIR15B | MIR16-1 | MIR16-2 | MIR17 | MIR17HG | MIR181A1 | MIR181A1HG | MIR181A2 | MIR181A2HG | MIR181B1 | MIR181B2 | MIR181C | MIR181D | MIR182 | MIR1825 | MIR1827 | MIR183 | MIR184 | MIR185 | MIR186 | MIR187 | MIR188 | MIR18A | MIR18B | MIR1908 | MIR1909 | MIR190A | MIR190B | MIR191 | MIR1910 | MIR1911 | MIR1912 | MIR1913 | MIR1914
